Health Policy
Health Policy
","url":"http:\/\/www.efda.gov.et\/"}},"mobileHeader":{"firstSwitchPoint":990,"secondSwitchPoint":778,"firstSwitchPointHeight":80,"secondSwitchPointHeight":60},"stickyMobileHeaderFirstSwitch":{"logo":{"html":""}},"stickyMobileHeaderSecondSwitch":{"logo":{"html":""}},"content":{"textColor":"#8c95a2","headerColor":"#133d58"},"boxedWidth":"1340px","stripes":{"stripe1":{"textColor":"#dbdbdb","headerColor":"#ff9f1a"},"stripe2":{"textColor":"#333333","headerColor":"#203961"},"stripe3":{"textColor":"#000000","headerColor":"#203961"}}},"VCMobileScreenWidth":"778"};
var dtShare = {"shareButtonText":{"facebook":"Share on Facebook","twitter":"Tweet","pinterest":"Pin it","linkedin":"Share on Linkedin","whatsapp":"Share on Whatsapp","google":"Share on Google Plus"},"overlayOpacity":"85"}; /* ]]> */
Definition of Powers and Duties of the Executive Organs Proclamation No. 1263-2021
SUMMARY OF PRODUCT CHARACTERISTICS TEMPLATE FOR Applicants
PATIENT INFORMATION LEAFLET (PIL)TEMPLATE FOR Applicants
Magnesium sulfate-Kalceks 500 mg per ml solution for injection_ Public assessment summary report_Package label
OCTANATE 500 and OCTANATE 1000 _SUMMARY OF PRODUCT CHARACTERISTICS
OCTANATE 500 and OCTANATE 1000 _ Public assessment summary report
Utrogestan Vaginal 100 mg and 200 mg Soft capsules _ Public assessment summary report_Package label
Utrogestan Vaginal 100 mg and 200 mg Soft capsules_SUMMARY OF PRODUCT CHARACTERISTICS
Minox 5, 50 mg ml, cutaneous solution_SUMMARY OF PRODUCT CHARACTERISTICS